# FDA Inspection 1309212 - Marek Smilowski - March 06, 2026

Source: https://www.keypedia.com/records/fda_inspections/marek-smilowski/7dc8b7ad-a60b-404f-983f-b93786f449c5
Source feed: FDA_Inspections

> FDA Inspection 1309212 for Marek Smilowski on March 06, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309212
- Company Name: Marek Smilowski
- Inspection Date: 2026-03-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1309212 - 2026-03-06](https://www.keypedia.com/records/fda_inspections/marek-smilowski/205bacbc-4b5d-4749-bb4d-656df4aa6db7)
- [FDA Inspection 1197431 - 2023-01-12](https://www.keypedia.com/records/fda_inspections/marek-smilowski/0ea6a6f6-f1ca-486c-8e36-643b05ed527b)

Company: https://www.keypedia.com/companies/marek-smilowski/10295795-a8df-432e-bc23-7cb9fe4a3db8